Intelligence · Clinical pipeline
Oncology · Phase II
Oncology programs at Phase II — ClinicalTrials.gov pipeline intelligence.
Quick answer
Oncology Phase II programs: NovaPharmaNews indexes 2,637 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- First People's Hospital 261 programs
- Chinese Academy of 198 programs
- George Institute for 118 programs
- United Therapeutics Europe 112 programs
- Telethon Foundation 91 programs
- Takeda 79 programs
- Regeneron UK 71 programs
- MSD Merck Sharp 63 programs
- Ningbo Cancer Hospital 62 programs
- Anaxis Pharma 57 programs
- AstraZeneca 52 programs
- HOFFMANN-LA ROCHE 50 programs
Pipeline programs
-
Zilovertamab vedotin
Merck Sharp and Dohme
Hematologic Malignancies or Solid Tumors in Pediatric and Young Adults
1 trial -
Zimberelimab
Arcus Biosciences
Adenocarcinoma Stomach
1 trial -
Zimberelimab
Arcus Biosciences
Pancreatic Ductal Adenocarcinoma
1 trial -
Zimberelimab
Arcus Biosciences
Hepatobiliary Cancer
1 trial -
Zimberelimab
Arcus Biosciences
Melanoma
1 trial -
Zimberelimab (ZIM)
Arcus Biosciences
Lung Cancer
1 trial -
Zirconium Zr 89 Girentuximab
Telix Innovations
Clear Cell Renal Cell Carcinoma
1 trial -
Ziv-Aflibercept
Regeneron UK Limited
Uveal Melanoma
1 trial -
Zn-Telomir
Telomir Pharmaceuticals
Triple-Negative Breast Cancer (TNBC)
1 trial -
Zoladex
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Zumsemetinib
Aclaris Therapeutics
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
1 trial -
[177Lu]-NeoB solution for infusion, AAA503
Advanced Accelerator Applications
Solid tumors known to overexpress GRPR and with [68Ga]-NeoB lesion uptake.
1 trial -
[18F]Tetrafluoroborate
Disc Medicine
Differentiated Thyroid Cancer
1 trial -
[203Pb]Pb-PSV359
Perspective Therapeutics
Pancreatic Ductal Adenocarcinoma
1 trial -
[203Pb]VMT-α-NET
Perspective Therapeutics
Neuroendocrine Tumors Unresectable
1 trial -
[203Pb]VMT01
Perspective Therapeutics
Recurrent Melanoma (Skin)
1 trial -
[68Ga]BED003 injection
Blue Earth Diagnostics Ireland Ltd
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
1 trial -
abituzumab
United Therapeutics Europe Ltd
Metastatic Colorectal Cancer
1 trial -
aflibercept + FOLFIRI
Regeneron UK Limited
Metastatic Colorectal Cancer
1 trial -
aglatimagene besadenovec
Candel Therapeutics
Prostate Cancer
1 trial -
aglatimagene besadenovec + valacyclovir
Candel Therapeutics
Prostate Cancer Patients Treated by Radiotherapy
1 trial -
alisertib
Takeda
Malignant Rhabdoid Tumor
1 trial -
alpha 1H, Placebo product for Alpha1H
Lacuna Pharma Pty Ltd
Non-muscle invasive bladder cancer awaiting transurethral surgery
1 trial -
anastrozole
Atrium Therapeutics
Female Breast Carcinoma
1 trial -
anlotinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcoma, Soft Tissue
1 trial -
anlotinib
Fudan University
Extensive-stage Small Cell Lung Cancer
1 trial -
anlotinib +TQB2450 + Oxaliplatin+S-1
The First People's Hospital of Lianyungang
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
1 trial -
anlotinib combined with penpulimab
The First People's Hospital of Lianyungang
Non-small Cell Lung Cancer
1 trial -
anlotinib+TQB2450+nab-paclitaxel+cisplatin
The First People's Hospital of Lianyungang
Advanced Biliary Tract Cancer
1 trial -
anti-BCMA CAR-T
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Plasma Cell Leukemia
1 trial -
anti-CD133-CAR vector-transduced T cells
Chinese PLA General Hospital
Liver Cancer
1 trial -
anti-CD7 CAR-pNK cells
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
anti-FLT3 CAR-T
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
anti-MUC1 CAR-pNK cells
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
artesunate
Hospital Authority, Hong Kong
Colorectal Cancer
1 trial -
asparaginase Erwinia chrysanthemi
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia
1 trial -
auranofin
Ultragenyx UK Limited
Chronic Lymphocytic Leukemia (CLL)
1 trial -
autologous dendritic cells pulsed with tumor lysate antigen Vaccine
NORTHWEST BIOTHERAPEUTICS INC
Giant Cell Glioblastoma
1 trial -
avelumab
Samsung Bioepis NL B.V.
Lymphoma, Extranodal NK-T-Cell
1 trial -
avelumab
Nektar Therapeutics UK Limited
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
1 trial -
avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Metastatic Cancer
1 trial -
azenosertib
Zentalis Pharmaceuticals
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
1 trial -
befotertinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC (Non-small Cell Lung Cancer)
1 trial -
bendamustine
Teva Pharma GmbH
Hodgkin Lymphoma
2 trials -
bendamustine and rituximab
Teva Pharma GmbH
Non-Hodgkin's Lymphoma
1 trial -
bevacizumab
United Therapeutics Europe Ltd
Colorectal Cancer
1 trial -
bevacizumab [Avastin]
Hoffmann-La Roche
Liver Cancer
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Breast Cancer
1 trial
Frequently asked questions
How many oncology Phase II programs exist?
2,637 programs match both the therapeutic area and stage filters in our published index.